Free Trial
NASDAQ:CYAN

Cyanotech 2/8/2024 Earnings Report

Cyanotech EPS Results

Actual EPS
-$0.16
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Cyanotech Revenue Results

Actual Revenue
$5.58 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Cyanotech Announcement Details

Quarter
Time
N/A
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Cyanotech Earnings Headlines

Is Elon's empire crumbling?
The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as July 23rd.
Q3 2025 Cyanotech Corp Earnings Call
See More Cyanotech Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Cyanotech? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Cyanotech and other key companies, straight to your email.

About Cyanotech

Cyanotech (NASDAQ:CYAN) Corp. engages in the cultivation, production, and sale of natural products derived from microalgae for the health and human nutrition markets worldwide. Its products include BioAstin Hawaiian Astaxanthin, a dietary antioxidant, which is used as a human dietary supplement and dietary ingredient to support and maintain the body's natural inflammatory response, enhance skin, and support eye, joint, and immune health; and Hawaiian Spirulina Pacifica, a nutrient-rich dietary supplement that is used for extra energy, a strengthened immune system, cardiovascular benefits, and as a source of antioxidant carotenoids. The company was founded by Gerald R. Cysewski in 1983 and is headquartered in Kailua-Kona, HI.

View Cyanotech Profile

More Earnings Resources from MarketBeat